Idiopathic Pulmonary Fibrosis Prespective Outcomes (IPF-PRO) Registry
Clinical Trial Grant
Administered By
Medicine, Pulmonary, Allergy, and Critical Care Medicine
Awarded By
Boehringer Ingelheim Pharmaceuticals, Inc.
Start Date
May 1, 2014
End Date
November 30, 2024
Administered By
Medicine, Pulmonary, Allergy, and Critical Care Medicine
Awarded By
Boehringer Ingelheim Pharmaceuticals, Inc.
Start Date
May 1, 2014
End Date
November 30, 2024